Benign prostatic hyperplasia (BPH) is one of the most common urinary diseases affecting
men, generally after the age of 50. The prevalence of this multifactorial disease increases …

Benign prostatic hyperplasia (BPH) is one of the most common urological diseases in aging
men. Because of its long latency, BPH is a good target for prevention. The aim of the study …

Uncontrolled epithelial cell proliferation in the prostate transition zone and the hyper-
accumulation of mesenchymal-like cells derived from the epithelial-mesenchymal transition …

Benign prostatic hyperplasia (BPH) is a common disease among aging males. We obtained
BPH transcriptional signatures by high-throughput RNA sequencing analysis. Accordingly …

This study determined whether or not benign prostatic hyperplasia (BPH) induced by a high-
fat diet (HFD) is involved in inflammatory responses, apoptosis, and the signal transducer …

Prunus africana–an evergreen tree found in Afromontane forests–is used in traditional
medicine to cure benign prostate hyperplasia. Different bioactive constituents derived from …

Benign prostatic hyperplasia (BPH) describes the non-malignant enlargement of the
prostate. It is both common and growing in incidence. Treatment is multimodal, involving …

Benign prostatic hyperplasia (BPH) is a chronic condition common in older men that can
result in bothersome lower urinary tract symptoms. The molecular mechanisms and …

Benign prostatic hyperplasia (BPH) is a common male condition that impacts many men's
quality of life by generating lower urinary tract symptoms (LUTS). In recent years …

OBJECTIVE: The aim of the clinical trial was to evaluate the efficacy and safety of
ProstateEZE Max, an orally dosed herbal preparation containing Cucurbita pepo, Epilobium …